BUZZ-艾伯维因 14 亿美元收购阿尔茨海默氏症疗法开发商 Aliada 的交易而上涨

Reuters
28 Oct 2024

((自动化翻译由路透提供,请见免责声明 ))

10月28日 - ** 制药商艾伯维 股价上涨1.06%,报189.82美元

** 该公司将以 14 亿美元现金收购 (link) Aliada Therapeutics,从而获得这家私营疗法开发商的阿尔茨海默病候选药物。

** Aliada正在开发ALIA-1758,这是一种处于早期开发阶段的治疗阿尔茨海默病的抗体,艾伯维称它可能成为一种最佳疗法

** 交易预计在 2024 年第四季度完成

** 包括本交易日的走势在内,ABBV股价今年累计上涨约23

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10